Night-to-night variability of apneas on overnight polysomnography exists in patients with documented obstructive sleep apnea (OSA). In this study, we evaluated the possibility that this variability may be severe enough to miss the diagnosis of OSA in patients clinically at risk for the disease. We prospectively studied 11 patients who were deemed on clinical grounds to have probable OSA, but had a negative result on overnight polysomnography. Six of the 11 patients were found to have a positive second study with a significant rise in the apnealhypopnea index (AHI) from 3.1 2 1.0 to 19.8 f 4.7 (mean f SEM, p<0.01). The cause of the negative first study in these patients is unclear, but it does not seem e identification of patients with obstructive sleep Th apnea ' (OSA) requires the demonstration of obstructive apneic and/or hypopneic events on overnight polysornnography.'" It has been suggested, however, that night-to-night variability exists in OSA, and that overnight polysomnography may actually miss significant abn~rmalities.~-~ Wittig et aI4 evaluated the nightto-night variability of apneas in patients with documented OSA and found that those with infrequent apneas (< 100 per night) had a higher level ofvariability than those patients with frequent apneas (>loo per night). Because of this finding, the authors concluded that the population of patients with mild OSA may be more difficult to diagnose, and that more than one study may be required to document the severity of disease.
Bliwise et in 1991, presented a study evaluating nightly variability of sleep-disordered breathing in 71 normal elderly volunteers. They performed two consecutive sleep studies in these patients, and found two groups of patients defined by the variability in the apneahypopnea index (AHI) between the two nights. Those with a change in AH1 of >10 were placed in the high variability group, and those with a change of <lo were placed in the low variability group. If patients in either group were being evaluated for OSA, related to risk factor pattern, sleep architecture, or test interval. The change in AH1 was not found to be rapid eye movement (REM)-dependent. This study demonstrates that a negative first-night study is insufficient to exclude OSA in patients with one or more clinical markers of the disease.
( In patients with OSA, a falsely negative overnight sleep study could have important adverse medical consequences. Recently, Dean and Chaudhary7 described nine patients with OSA who had a negative first night study and a positive second night study as defined by an apnea index of >5. Despite demonstrating this important finding, the study is limited by its retrospective design, diagnostic criteria for OSA, and long interval between studies of up to 50 months.
Recently, Crocker et aln suggested that the presence of significant OSA could be predicted by the clinical criteria of witnessed apneic episodes, hypertension age, and obesity as defined by an increased body mass index (BMI). One of the authors of this study had previously communicated these results at our institution (N.S., 1989). To investigate the potential discrepancy between clinical suspicion of disease and negative overnight polysomnography, we utilized these criteria to prospectively evaluate all patients who were suspected on clinical grounds to have probable OSA, but had a negative result on first-night polysomnography. In each case, it was believed that OSA was missed and a repeated study was performed as soon as possible. Overnight polysomnography was performed in all patients using standard electroencephalogram (EEG), electro-oculogram (EOG), and submental electromyogram (EMG) monitoring for sleep staging. Respirations were monitored using chest and abdominal impedance plethysmography and surface intermstal EMGs. Airflow was assessed with oral and nasal thermistors, and arterial oxygen saturation was monitored using mntinuous pulse oximetry. Baseline arterial oxygen saturation was measured while the patient was awake. Nadir arterial oxygen saturation levels were obtained from the polysomnogram. Heart rate and rhythm were monitored with cnntinrlorls electrocardiogram (ECG) recording. Noch~rnd myoclonus was monitored using bilateral tibialis EMG leads. Obstn~ctive apneas were defined as a cessation of airflow for >10 s with continued chest and abdominal efforts. Obstructive hypnpneas were defined as a decrease in airflow of at least 50 percent associated with at least a 4 percent decrease in oxygen saturation. The apneahypopnea index (number of apneas and hypopneas per hour) was used to diagnose O S A . ,~ The study was mnsidered negative if the apneal hypopnea index (AHI) was 5 5 , and positive if the AH1 was 2 10.
Eleven patients were considered to have a high clinical risk for OSA and had a nondiagnostic first night study. Because of the high clinical suspicion, a secund all-night sleep study was expediently performed to exclude the possibility of a false-negative first night study.
Statistical analysis was performed using a n)mputer program (Statview SE +Graphics, Abacus Concepts Inc, Berkeley, Calif). Paired, two tailed Student's t tests were performed on data within each group, and unpaired, two tailed Student's t tests were performed on data between the groups. Arcsin transformation was performed on sleep stage percentage and efficiency values prior to Student's t test analysis. P values of <0.05 were mnsidered significant.
As shown in Figure 1 , 6 of the 11 patients in this study (group A) had a positive second night study with a mean AH1 of 19.8k4.7 (mean 2SEM) compared with a first night AH1 of 3.1k 1.0 (pC0.05). The remaining five patients (group B) had a negative second night study with no significant increase in AH1 between the first and second nights (1.120.6 and 2.4k0.7, respectively). The first and second night apnea indices (AI) for group A were 1 . 4 k 0 . 9 and 5.5 2 2.3 (p = 0.21), respectively, and for group B were 0.1 k 0.1 and 0.5 + 0.2 (p = 0.22), respectively. There were no significant differences between the first and second nights within each group with respect to sleep staging, total sleep time, sleep efficiency, or 0, saturation in either group (see Table 1 ).
When the two groups are compared, one can see that group A has a significantly greater percentage of stage 1 sleep on night 2 than group B (23.0k3.5 and 11.4 + 3.1, respectively, pC0.05). The second night nadir 0, saturation was lower in group A than group B (90.2 + 1.0 and 93.8 + 0.5, respectively, pC0.05).
The second night AH1 of group A was also significantly greater than that of group B (19.8 f 4.7 and 2.4 + 0.7, respectively, p<0.01). The second night A1 of group A was greater than that of group B, but this did not reach statistical significance (5.5 + 2.3 and 0.5 + 0.2, respectively, p = 0.08).
Individual patient characteristics, risk factor patterns, and test intervals are shown in Table 2 . There were no significant differences between the groups with respect to mean age, BMI, number of risk factors, or test interval. The mean test intervals for groups A and B were 7 . 0 2 2 . 3 weeks and 8 . 6 2 2 . 9 weeks, respectively. All patients had a history of snoring, and daytime somnolence was the presenting complaint in all group A patients and in three of the group B patients. The remaining two group B patients initially complained of insomnia.
The AH1 for each group was analyzed by the number of events per hour of nonrapid eye movement (NREM) and rapid eye movement (REM) sleep (NREM and REM index, respectively). The group A NREM and REM indices both increased significantly on the second night from 3.1 k 1.1 to 20.3 2 5.6 (pC0.05) and 2.2 + 1.5 to 15.3+ 4.0 (p<0.05), respectively. However, there was no statistical difference in the amount of increase in either index. This suggests that the increase in AH1 on the second night was not related to a selective increase in events during REM or NREM sleep.
The results of this study clearly demonstrate that a single negative sleep study is insufficient to exclude OSA in patients with one or more clinical markers for the disease. It is not clearly apparent, however, why one group of patients developed a positive second night study, and the other group did not. The two groups of patients in this study were similar with respect to age, risk factor pattern, and test interval. There were also no significant difFerences in sleep architecture within each group between the two nights of testing. The only sleep parameter differences between the groups was the significant rise in AH1 and stage 1 sleep seen in group A on the second night of testing. The decrease in nadir 0, saturation and increase in stage 1 sleep in this group is not surprising given the significant rise in obstructive events and the subsequent fragmentation of sleep.
Dean and Chaudhary7 report similar findings; however, their study ditl'ers from ours in several respects. They performed a second night study using different clinical indicators, specifically snoring, disturbed sleep, and daytime somnolence. We did not use these criteria since snoring and daytime somnolence were not found to be significant predictive clinical markers by Crocker et Of the nine patients in their review, only three had a first night AH1 of <5 necessary to meet the rigid criteria used in our study, and three other patients had a first night AH1 of >10 which would have been sufficient for the diagnosis of OSA in our study. The two nights of study were also separated by a long mean interval of 18.7 months in their study, compared with the shorter test interval in our study. Changes in medical condition, body weight, or medication use are more likely to occur in the longer test interval and possibly influence test results. Comparison of the two nights in their study revealed a significantly reduced total sleep time (TST) and total hours of REM sleep on the first night. However, the percentage of REM sleep per night was not significantly different between the two nights, which is similar to our findings. The authors suggest that the reduction in apneas seen on the first night might be explained by the reduction in total hours of REM seen. Our findings do not support this theory as there was an equivalent increase in apneic events during REM and NREM sleep.
There are several possible reasons for a first-night study to miss the diagnosis of OSA in a patient with high clinical suspicion for the disease. It is postulated that snoring and OSA represent the two extremes of a spectrum of sleep disturbance determined by the degree of upper airway re~istance.~ Thus, one could postulate that pharyngeal resistance was not high enough on the baseline study in group A to produce classic apneas and hypopneas, but became high enough on the second night. This does not mean, however, that pharyngeal resistance was normal on the first night. There still could have been some elevation of upper airway resistance leading to snoring and even daytime sleepiness.
One factor that can affect the magnitude of upper ainvay resistance is nasal occlusion; the greater the degree of occlusion, the higher the re~istance.~" Night-to-night variability in nasal resistance may, One Negative Fbiysomnogram Does Not Exclude OSA (Meyer et a/) therefore, result in variability of snoring or the actual absence or presence of apneas and hypopneas. It is certainly possible that there could have been a greater degree of nasal resistance on the second night in our patients who developed positive results. In support of this, Bliwise et a15 found a greater degree of nasal congestion in patients with a highly variable AHI.
Upper airway resistance can also be increased in the supine position when the jaw and tongue fall back with gravity. In fact, supine sleep apnea is a documented clinical entity.12.13 It is possible that the group A patients spent more time on their back on the second night than on the first. Unfortunately, our study lacks reliable data of gross body position during polysomnography. Gross body position, however, was not shown to be a significant factor in the development of apneas by Bliwise et a15 or Dean and Chaudhary.' In addition, we did not perform cephalometric measurements on our patients. This may have yielded upper airway anatomic information to explain the difference seen in the groups. It is possible, for example, that the patients in group A had longer soft palates than those in group B, predisposing them to apneic episodes under conditions of nasal congestion or perhaps supine body position.
The consumption of alcohol is known to increase the frequency and duration of obstructive apneic events, perhaps by the reduction of upper airway muscle activity a n d suppression of arousal r es p o n s e~.~~.~~ It is possible that the patients in group A ingested alcohol prior to the second night of study resulting in an increased AHI. However, all patients evaluated at our sleep center are specifically instructed to abstain from alcohol prior to poly~omnograph~. Alcohol, therefore, is unlikely to be an exacerbating agent in our patients.
The timing of the second study might be etiologically important. Prior to the initiation of this study, we treated a patient at our center who clearly had worsened obstructive apnea at the end of the work week. This may have been related to increased fatigue and sleep deprivation that increased during the week and resolved somewhat on the weekend. Since sleep deprivation has been shown to blunt the ventilatory response of the genioglossus muscle to CO,,lfi one could postulate that progressive sleep deprivation during the work week might promote pharyngeal collapse. In our present study, however, there was no difference seen in the timing of the second study in either group. Tuesday was mean first study day, and Wednesday was the mean second study day in each group.
Another possible explanation for our findings is the "first night effect"17 in which patient sleep is unreliable secondary to the sleep laboratory environment. If this had played a role in our study, a difference in sleep parameters within the groups behveen the hvo nights of study should have been found. Since this was not seen, a "first night effect'' is less likely to be an important factor.
The second negative study in the group B patients raises the issue of how many negative studies are sufficient to safely exclude this disease. Recently, Dean and Chaudhary6 described three patients who required three sleep studies to diagnose OSA using an A1 of >5 as the diagnostic criterion. It is possible, therefore, that a third sleep study would diagnose OSA in some of the group B patients. We did not pursue a third study in these patients for several reasons. First, the predictive value of one or hvo clinical risk factors as defined by Crtxker et alx is not absolute, and, therefore, one would expect some of these patients not to have disease. Second, an increase in age is associated with an increase in the risk for OSA.n Although the age daerence behveen group A and group B did not reach statistical significance (p=0.06), the patients in group B tended to be younger. We considered the younger age to place them at lower risk for the disease. Finally, multiple sleep latency tests (MSLT)Ix were performed in hvo of the group B patients because of persistent complaints of daytime somnolence, and both showed no abnormalities. We believed that the presence of hvo negative sleep studies and a negative MSLT was sufficient to exclude OSA in these patients despite their risk factors.
Overnight polysomnography is the diagnostic gold standard for OSA. However, it is known that night-tonight variability in apneas exists in patients with documented OSA, raising the possibility of missing the diagnosis of this serious disease. Our prospective study shows that a significant number of patients with OSA can be missed with one study alone. These patients all presented with significant predictive clinical risk factors for OSA. Reasons for a negative first study are not readily apparent, but it does not seem related to sleep architecture, risk factor pattern, or test interval. The equivalent increase in apneas during NREM and REM sleep in our study suggests that a first-night paucity of REM sleep is not a factor. Nasal patency, abnormal upper airway anatomy, or possibly disruptive environmental factors may all be important variables in the genesis of night-to-night variability of OSA. 
